日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MEK inhibitor mirdametinib promotes fracture healing in osteofibrous dysplasia RASopathy

MEK抑制剂mirdametinib可促进骨纤维发育不良RAS病患者的骨折愈合。

Khalid, Aysha B; Denton, Kristin; Paria, Nandina; Oxendine, Ila; Wassell, Meghan; Cornelia, Reuel; Uppuganti, Sasidhar; Nyman, Jeffry S; Jagadeesh, G Jayashree; Ferreira, Carlos R; Conway, Simon J; Hammer, Robert E; Ritter, John; Nguyen, Mylinh; Podeszwa, David A; Klesse, Laura J; Wise, Carol A; Rios, Jonathan J

Molecular Evidence Supporting MEK Inhibitor Therapy in NF1 Pseudarthrosis

分子证据支持MEK抑制剂疗法治疗NF1假关节

Paria, Nandina; Oxendine, Ila; Podeszwa, David; Wassell, Meghan; Cornelia, Reuel; Wise, Carol A; Rios, Jonathan J

Dominant missense variants in SREBF2 are associated with complex dermatological, neurological, and skeletal abnormalities.

SREBF2 中的显性错义变异与复杂的皮肤病、神经系统疾病和骨骼疾病有关

Moulton Matthew J, Atala Kristhen, Zheng Yiming, Dutta Debdeep, Grange Dorothy K, Lin Wen-Wen, Wegner Daniel J, Wambach Jennifer A, Duker Angela L, Bober Michael B, Kratz Lisa, Wise Carol A, Oxendine Ila, Khanshour Anas, Wangler Michael F, Yamamoto Shinya, Cole F Sessions, Rios Jonathan, Bellen Hugo J